Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Daiichi Sankyo
Harvard Business School
Farmers Insurance
Moodys

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 8,637,531

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,637,531
Title:Pyrido(3,2-d)pyridmidines useful for treating viral infections
Abstract: This invention provides pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (I), wherein: R.sub.1 is amino, R.sub.4 is hydrogen, and R.sub.2 and R.sub.3 together provide a specific substitution pattern, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, are useful in the treatment of hepatitis C.
Inventor(s): Bondy; Steven S. (Danville, CA), Watkins; William J. (Saratoga, CA), Chong; Lee S. (Newark, CA), Herdewijn; Piet Andre Maurits Maria (Rotselaar/Wexemaal, BE), De Jonghe; Steven Cesar Alfons (Brugge, BE)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:12/519,500
Patent Claims:see list of patent claims

Details for Patent 8,637,531

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) 2026-12-26 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Sign Up Gilead Sciences, Inc. (Foster City, CA) 2026-12-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
UBS
Accenture
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.